| abstract |
The use of calcitonin in the manufacture of a medicament for the treatment of an inflammatory disease or condition is provided. Calcitonin can be selected from the group consisting of human, salmon, eel, pig, bovine or chicken calcitonin or derivatives thereof, fragments thereof or variants thereof. The inflammatory disease or condition may be rheumatoid arthritis (RA), juvenile rheumatoid arthritis (JRA), osteoarthritis, psoriasis, psoriatic arthritis, ankylosing spondylitis (AS), lupus erythematosus, multiple sclerosis (MS), asthma or immunosuppressive therapy have. The treatment may also include the administration of glucocorticoids, antirheumatic drugs or antibodies. |